[2-[[(1-Chloroethoxy)carbonyl](methyl)amino]pyridin-3-yl]methyl 2-[(tert-Butoxycarbonyl)(methyl)amino]acetate can be used for pharmaceutical composition containing STING agonistic compound and antitumor agent.
More information please send email to: pharmchem4@ichemie.com
*The following content is generated by AI and is for reference only.
The chemical entity described by the name "(2-(((1-Chloroethoxy)carbonyl)(methyl)amino)pyridin-3-yl)methyl 2-((tert-butoxycarbonyl)(methyl)amin" appears to be a specialized, partially defined organic intermediate or a fragment of a larger peptide-mimetic structure rather than a standard commercial commodity with a widely recognized CAS number in public databases. Based on the structural components provided, this molecule likely represents a protected amino acid derivative or a building block designed for solid-phase peptide synthesis (SPPS) or medicinal chemistry applications. The presence of the tert-butoxycarbonyl (Boc) group indicates protection of an amine functionality, while the pyridine ring suggests potential involvement in heterocyclic chemistry or as a scaffold for bioactive compounds. The chloroethoxycarbonyl moiety is less common and may serve as a specific protecting group or a reactive handle for further derivatization, although its stability under standard conditions would require verification.
Due to the incomplete nature of the provided nomenclature, which ends abruptly at "amin," a precise molecular formula and exact CAS registry number cannot be definitively assigned without the full structural context. In professional chemical contexts, such fragments are typically synthesized in-house or sourced from specialized suppliers catering to research institutions developing novel therapeutics. These types of intermediates are crucial for constructing complex molecules targeting specific biological receptors, often found in the early stages of drug discovery pipelines. Their primary utility lies in their ability to facilitate selective coupling reactions while preventing unwanted side reactions through strategic protection strategies. Researchers utilize these compounds to explore structure-activity relationships (SAR), optimize lead compounds, and synthesize libraries for high-throughput screening. Given the complexity and specificity of the structure, handling requires adherence to strict laboratory safety protocols, including the use of appropriate personal protective equipment and ventilation systems, as many organic halides and carbamate derivatives can be irritants or sensitizers. Ultimately, while specific catalog data remains elusive due to the partial name, the compound class plays a vital role in advancing pharmaceutical research and the development of next-generation small molecule drugs.